V M Menezes1, B G O Soares, C J F Fontes. 1. Universidade Federal de Mato Grosso, Faculdade de Ciências Médicas, Av Fernando Correia da Costa S.N. Coxipó, Cuiabá MT, Brazil. vmen@terra.com.br
Abstract
BACKGROUND: Paracoccidioidomycosis is a fungal infection found in particular geographic localities in Latin America. Treatment can last for up to two years is often associated with complications, including relapse, but people may die without it. OBJECTIVES: To evaluate drugs used for treating paracoccidioidomycosis. SEARCH STRATEGY: We searched the Cochrane Infectious Diseases Group Specialized Register (January 2006), CENTRAL (The Cochrane Library 2005, Issue 4), PubMed (1966 to January 2006), EMBASE (1974 to January 2006), LILACS (1982 to January 2006), conference proceedings, and reference lists. We also contacted researchers and pharmaceutical companies. SELECTION CRITERIA: Randomized controlled trials comparing drugs for treating people with paracoccidioidomycosis. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial eligibility and methodological quality, and extracted data, including adverse events. MAIN RESULTS: One trial with 42 participants met the inclusion criteria that compared imidazoles (itraconazole and ketoconazole) with sulfadiazine. No difference was detected for cure or clinical improvement, or serological titres after 10 months of treatment, and there was no difference detected in adverse events. AUTHORS' CONCLUSIONS: The small number of participants and the short follow-up period impede definitive conclusions.
BACKGROUND:Paracoccidioidomycosis is a fungal infection found in particular geographic localities in Latin America. Treatment can last for up to two years is often associated with complications, including relapse, but people may die without it. OBJECTIVES: To evaluate drugs used for treating paracoccidioidomycosis. SEARCH STRATEGY: We searched the Cochrane Infectious Diseases Group Specialized Register (January 2006), CENTRAL (The Cochrane Library 2005, Issue 4), PubMed (1966 to January 2006), EMBASE (1974 to January 2006), LILACS (1982 to January 2006), conference proceedings, and reference lists. We also contacted researchers and pharmaceutical companies. SELECTION CRITERIA: Randomized controlled trials comparing drugs for treating people with paracoccidioidomycosis. DATA COLLECTION AND ANALYSIS: Two authors independently assessed trial eligibility and methodological quality, and extracted data, including adverse events. MAIN RESULTS: One trial with 42 participants met the inclusion criteria that compared imidazoles (itraconazole and ketoconazole) with sulfadiazine. No difference was detected for cure or clinical improvement, or serological titres after 10 months of treatment, and there was no difference detected in adverse events. AUTHORS' CONCLUSIONS: The small number of participants and the short follow-up period impede definitive conclusions.
Authors: Gilda M B Del Negro; Cristiane N Pereira; Heitor F Andrade; Selma A Palacios; Mônica M S Vidal; Cecília E Charbel; Gil Benard Journal: J Med Microbiol Date: 2000-01 Impact factor: 2.472
Authors: M A Shikanai-Yasuda; G Benard; Y Higaki; G M B Del Negro; Sun Hoo; E H Vaccari; R C B Gryschek; A A C Segurado; A A Barone; D R Andrade Journal: Med Mycol Date: 2002-08 Impact factor: 4.076
Authors: Ziadir Francisco Coutinho; Delson da Silva; Márcia Lazera; Valéria Petri; Rosely Magalhães de Oliveira; Paulo C Sabroza; Bodo Wanke Journal: Cad Saude Publica Date: 2002 Sep-Oct Impact factor: 1.632
Authors: Anamaria Mello Miranda Paniago; José Ivan Albuquerque Aguiar; Eliana Setti Aguiar; Rivaldo Venâncio da Cunha; Gracy Regina de Oliveira Leite Pereira; Alberto Thomaz Londero; Bodo Wanke Journal: Rev Soc Bras Med Trop Date: 2003-08-13 Impact factor: 1.581
Authors: Andreia F Nery; Natasha P Crepaldi; Soraya B R S Rossi; Tomoko Tadano; Fabio A Leal-Santos; Rosane Christine Hahn; Valfredo M Menezes; Cor Jesus F Fontes Journal: Am J Trop Med Hyg Date: 2017-07-19 Impact factor: 2.345
Authors: B Rammaert; M N Gamaletsou; V Zeller; C Elie; R Prinapori; S J Taj-Aldeen; E Roilides; D P Kontoyiannis; B Brause; N V Sipsas; T J Walsh; O Lortholary Journal: Eur J Clin Microbiol Infect Dis Date: 2014-06-18 Impact factor: 3.267
Authors: Erika Seki Kioshima; Patrícia de Souza Bonfim de Mendonça; Marcus de Melo Teixeira; Isis Regina Grenier Capoci; André Amaral; Franciele Abigail Vilugron Rodrigues-Vendramini; Bruna Lauton Simões; Ana Karina Rodrigues Abadio; Larissa Fernandes Matos; Maria Sueli Soares Felipe Journal: J Fungi (Basel) Date: 2021-02-02
Authors: Karen S Ferreira; Andrea Q Maranhão; Maria C C Garcia; Marcelo M Brígido; Suelen S Santos; José D Lopes; Sandro R Almeida Journal: PLoS One Date: 2011-01-07 Impact factor: 3.240